Amuza — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Amuza Inc., founded in 2015 and based in San Diego, CA, is a private company that has pivoted from its original description as a developer of drug delivery technologies and small molecule therapeutics. It now operates as a provider of specialized neuroscience research tools and services. The company's business model is focused on selling advanced instrumentation (like wireless optogenetics systems and HPLC-ECD detectors) and providing associated consulting and support services to research labs. Amuza is in a revenue-generating stage, serving a market of academic and institutional neuroscience researchers seeking to improve the precision and reliability of their experiments.

Neurological DisordersPsychiatric Disorders

Technology Platform

Integrated suite of neuroscience research tools including wireless optogenetics systems, HPLC-ECD for neurotransmitter analysis, operant conditioning behavioral systems, and rapid tissue clearing kits, supported by customization and expert consultation services.

Opportunities

Growing global investment in neuroscience research creates sustained demand for reliable, advanced tools.

The trend towards more complex, in vivo behavioral and circuit neuroscience experiments aligns perfectly with Amuza's integrated wireless and analytical solutions.

There is an opportunity to expand from a tools provider into a broader research services partner, offering experimental design and data analysis support.

Risk Factors

Revenue is heavily tied to the grant-dependent academic research sector, making it vulnerable to funding cycles.

The company faces competition from larger, established instrument manufacturers and must continuously innovate and maintain its high-touch service model to differentiate itself.

As a small private company, it has limited resources for R&D and market expansion.

Competitive Landscape

Amuza competes in the neuroscience research tools market against large players like Harvard Apparatus (a Harvard Bioscience company), San Diego Instruments, and Med Associates in behavior, and companies like BASi and Antec Scientific in HPLC-ECD. Its differentiation is based on deep application expertise, system integration (e.g., wireless opto + behavior), and a highly collaborative, consultative sales and support approach, rather than competing solely on price or instrument specifications.

More companies in Biologics / Biosimilars →More companies in United States →